cheaptrix/billsum-US_congress_and_house huggingface dataset:
Opioid Addiction Risk Transparency Act

To allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling. 1. Short title This Act may be cited as the Opioid Addiction Risk Transparency Act 2. REMS communication plans Section 505–1(e)(3) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1(e)(3) (1) in subparagraph (B), by striking ; or (2) in subparagraph (C), by striking the period and inserting ; or (3) by adding at the end the following: (D) disseminating information to health care providers about the meaning of terms related to drug formulations or properties that are described in the drug labeling, including information about the limitations or patient care implications of such formulations or properties, and how such formulations or properties may be related to serious adverse drug events associated with use of the drug. .

Summary: Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
A bill to require the Secretary of the Interior to issue new resource management plans applicable to the Beaver Dam Wash National Conservation Area and the Red Cliffs National Conservation Area and a new amendment to the St. George Field Office Resource Management Plan, and for other purposes.

To require the Secretary of the Interior to issue new resource management plans applicable to the Beaver Dam Wash National Conservation Area and the Red Cliffs National Conservation Area and a new amendment to the St. George Field Office Resource Management Plan, and for other purposes. 1. Issuance of new resource management plans for the Beaver Dam Wash and Red Cliffs National Conservation Areas and a new amendment to the St. George Field Office Resource Management Plan The Secretary of the Interior (acting through the Director of the Bureau of Land Management)— (1) shall not implement or enforce the resource management plans for the Beaver Dam Wash National Conservation Area or the Red Cliffs National Conservation Area or the amendment to the St. George Field Office Resource Management Plan described in the notice of the Bureau of Land Management entitled Notice of Availability of the Record of Decision and the Approved Resource Management Plans for the Beaver Dam Wash and Red Cliffs National Conservation Areas; and Approved Amendment to the St. George Field Office Resource Management Plan in Washington County, Utah (2) shall issue new resource management plans and a new amendment to replace the resource management plans and amendment to the resource management plan referred to in paragraph (1) that are prepared— (A) in accordance with the requirements for management plans established under subtitle O of title I of the Omnibus Public Land Management Act of 2009 ( Public Law 111–11 (B) in coordination with affected units of local government, in accordance with section 202(c)(9) of the Federal Land Policy and Management Act of 1976 ( 43 U.S.C. 1712(c)(9)

Summary: This bill prohibits the Bureau of Land Management (BLM) from implementing or enforcing: (1) the resource management plans for the Beaver Dam Wash National Conservation Area or the Red Cliffs National Conservation Area in Utah; or (2) the amendment to the St. George Field Office Resource Management Plan described in the notice of the BLM titled "Notice of Availability of the Record of Decision and Approved Resource Management Plans for the Beaver Dam Wash and Red Cliffs National Conservation Areas; and Approved Amendment to the St. George Field Office Resource Management Plan in Washington, County, Utah" (published in the Federal Register on December 21, 2016). In their place the BLM shall issue new resource management plans and a new amendment that are prepared: (1) in accordance with the requirements for comprehensive plans for the long-term management of such conservation areas under the Omnibus Public Land Management Act of 2009, and (2) in coordination with affected local governments in accordance with certain criteria for the development and revision of land use plans under the Federal Land Policy and Management Act of 1976.
Dynamic Glass Act

To amend the Internal Revenue Code of 1986 to ensure that electrochromic glass qualifies as energy property for purposes of the energy credit. 1. Short title This Act may be cited as the Dynamic Glass Act 2. Inclusion of electrochromic glass as energy property (a) In general Clause (i) of section 48(a)(3)(A) (including use of electrochromic glass) a structure (b) Effective date The amendment made by this section shall apply to taxable years beginning after the date of the enactment of this Act.

Summary: Dynamic Glass Act This bill amends the Internal Revenue Code to specify that the use of electrochromic glass qualifies for the tax credit for investment in energy property. (Electrochromic glass is able to switch from clear to dark using a switch, sensor, timer, or similar controls.)
National Flood Insurance Program Consultant Accountability Act of 2017

To authorize the Administrator of the Federal Emergency Management Agency to terminate certain contracts on the basis of detrimental conduct to the National Flood Insurance Program, and for other purposes. 1. Short title This Act may be cited as the National Flood Insurance Program Consultant Accountability Act of 2017 2. Termination of certain contracts under the National Flood Insurance Program (a) In general Part C of chapter II National Flood Insurance Act of 1968 ( 42 U.S.C. 4081 1349. Termination of contracts (a) Definition In this section— (1) the term covered entity (2) the term Write Your Own company (b) Termination (1) In general Notwithstanding any other provision of law, the Administrator may terminate a contract or other agreement between a covered entity and a Write Your Own company if the Administrator— (A) determines that the covered entity has engaged in conduct that is detrimental to the flood insurance program authorized under chapter I; and (B) not later than 14 days before terminating the contract or other agreement, provided notice to the covered entity of the termination. (2) Appeal The Administrator shall establish a process for a covered entity to appeal a termination of a contract or other agreement under paragraph (1). (3) Early termination payouts The Administrator or a Write Your Own company is not required to make any early termination payout to a covered entity with respect to a contract or agreement with the Write Your Own company that the Administrator terminates under paragraph (1). . (b) Effective date; applicability The amendment made by subsection (a) shall— (1) take effect on the date of enactment of this Act; and (2) apply to any contract or other agreement between a covered entity and a Write Your Own company (as those terms are defined in section 1349(a) of the National Flood Insurance Act of 1968, as added by subsection (a)) entered into on or after the date of enactment of this Act.

Summary: National Flood Insurance Program Consultant Accountability Act of 2017 This bill amends the National Flood Insurance Act of 1968 to allow the Federal Emergency Management Agency (FEMA) to terminate certain contracts under the National Flood Insurance Program on the basis of detrimental conduct to the program by a "covered entity" (an attorney, law firm, consultant, or third-party company that provides certain services under the contract). Specifically, on such basis, FEMA may terminate a contract between a covered entity and a "Write Your Own" company (a property and casualty company that writes and services standard flood insurance policies in its own name). FEMA shall establish a process for a covered entity to appeal such a termination. Neither FEMA nor a Write Your Own company is required to make an early-termination payout to a covered entity with respect to a contract terminated under the bill.
Responsible Disposal Reauthorization Act of 2017

To extend the authorization of the Uranium Mill Tailings Radiation Control Act of 1978 relating to the disposal site in Mesa County, Colorado. 1. Short title This Act may be cited as the Responsible Disposal Reauthorization Act of 2017 2. Authorization Section 112(a)(1)(B) of the Uranium Mill Tailings Radiation Control Act of 1978 ( 42 U.S.C. 7922(a)(1)(B) September 30, 2023 September 30, 2048 May 10, 2018 Reported without amendment

Summary: Responsible Disposal Reauthorization Act of 2017 This bill amends the Uranium Mill Tailings Radiation Control Act of 1978 to extend through FY2048 authorization for the Department of Energy to operate the Cheney disposal cell in Mesa County, Colorado.
ObamaCare Repeal Act

To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 entirely. 1. Short title This Act may be cited as the ObamaCare Repeal Act 2. Repeal of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (a) Patient Protection and Affordable Care Act Effective on January 1, 2018, the Patient Protection and Affordable Care Act ( Public Law 111–148 (b) Health Care and Education Reconciliation Act of 2010 Effective on January 1, 2018, the Health Care and Education Reconciliation Act of 2010 ( Public Law 111–152 3. Budgetary effects of this Act The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation

Summary: ObamaCare Repeal Act This bill repeals the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 and restores provisions of law amended by those Acts, effective January 1, 2018.
A bill to designate Union Station in Washington, DC, as "Harry S. Truman Union Station".

To designate Union Station in Washington, DC, as Harry S. Truman Union Station 1. Harry S. Truman Union Station (a) Designation Union Station, located at 40 Massachusetts Avenue, NE, Washington, DC, shall be known and designated as Harry S. Truman Union Station (b) References Any reference in a law, map, regulation, document, paper, or other record of the United States to the facility referred to in subsection (a) shall be deemed to be a reference to the Harry S. Truman Union Station

Summary: This bill designates Union Station, located at 40 Massachusetts Avenue, NE., Washington, DC, as the "Harry S. Truman Union Station."
Federal Adjustment in Reporting Student Credit Act of 2017

To provide for the removal of default information from a borrower’s credit report with respect to certain rehabilitated education loans. 1. Short title This Act may be cited as the Federal Adjustment in Reporting Student Credit Act of 2017 FAIR Student Credit Act of 2017 2. Rehabilitation of qualified education loans Section 623(a)(1) of the Fair Credit Reporting Act ( 15 U.S.C. 1681s–2(a)(1) (E) Rehabilitation of qualified education loans (i) In general Notwithstanding any other provision of this section, a person may request to remove a previously reported default regarding a qualified education loan from a consumer report, and such request shall not be considered inaccurate, if— (I) the lender chooses to offer a loan rehabilitation program that requires a number of consecutive on-time monthly payments, in accordance with the terms and conditions of the loan rehabilitation program, or any valid and legally binding modification thereto, equal to the number of payments specified under section 428F(a)(1)(A) of the Higher Education Act of 1965 ( 20 U.S.C. 1078–6(a)(1)(A) (II) the consumer of such loan successfully and voluntarily meets the requirements of that loan rehabilitation program. (ii) Limitation A consumer may obtain the benefits available under this subsection with respect to rehabilitating a loan only one time per loan. (iii) Qualified education loan defined For purposes of this subparagraph, the term qualified education loan section 221(d) . 3. GAO Study (a) Study The Comptroller General of the United States shall carry out a study on— (1) the implementation of section 623(a)(1)(E) of the Fair Credit Reporting Act, as added by section 2; and (2) any hurdles borrowers experience with the private loan rehabilitation program. (b) Report Not later than the end of the 18-month period beginning on the date of the enactment of this Act, the Comptroller General shall issue a report to the Congress containing all findings and determinations made in carrying out the study required under subsection (a).

Summary: Federal Adjustment in Reporting Student Credit Act of 2017 or the FAIR Student Credit Act of 2017 This bill amends the Fair Credit Reporting Act to allow a person to request the removal of a previously reported default regarding a qualified education loan from a consumer report if: (1) the lender chooses to offer a loan-rehabilitation program that requires a number of consecutive on-time monthly payments equal to the number of payments specified in a default reduction program under the Higher Education Act of 1965, and (2) the consumer of the loan successfully and voluntarily meets the requirements of that loan-rehabilitation program. A consumer may obtain such rehabilitation benefits only once per loan. The Government Accountability Office shall report on any hurdles borrowers experience with the private loan-rehabilitation program.
Electronic Signature Standards Act of 2017

To amend the Internal Revenue Code of 1986 to provide uniform standards for the use of electronic signatures for third-party disclosure authorizations. 1. Short title This Act may be cited as the Electronic Signature Standards Act of 2017 2. Uniform standards for the use of electronic signatures for third-party disclosure authorizations Paragraph (3) of section 6061(b) (3) Published guidance (A) In general The Secretary shall publish guidance as appropriate to define and implement any waiver of the signature requirements or any method adopted under paragraph (1). (B) Electronic signatures for third-party disclosure authorizations Not later than 6 months after the date of the enactment of this subparagraph, the Secretary shall publish guidance to establish uniform standards and procedures for the acceptance of practitioner signatures of digital or other electronic form for purposes of— (i) any request for disclosure of a taxpayer's return or return information under section 6103(c), and (ii) any power of attorney executed by the taxpayer. (C) Practitioner For purposes of subparagraph (B), the term practitioner .

Summary: Electronic Signature Standards Act of 2017 This bill amends the Internal Revenue Code to require the Internal Revenue Service to publish guidance to establish uniform standards and procedures for the acceptance of practitioner signatures in digital or other electronic form for the purposes of: (1) disclosures of tax returns and return information to a designee of the taxpayer, and (2) any power of attorney executed by the taxpayer.
Appalachian Ethane Storage Hub Study Act

To direct the Secretary of Energy and the Secretary of Commerce to conduct a study of the feasibility of establishing an ethane storage and distribution hub in the United States. 1. Short title This Act may be cited as the Appalachian Ethane Storage Hub Study Act 2. Ethane storage study (a) In general The Secretary of Energy (referred to in this section as the Secretary (b) Contents The study conducted under subsection (a) shall include— (1) an examination of, with respect to the proposed ethane storage and distribution hub— (A) potential locations; (B) economic feasibility; (C) economic benefits; (D) geological storage capacity capabilities; (E) above-ground storage capabilities; (F) infrastructure needs; and (G) other markets and trading hubs, particularly hubs relating to ethane; and (2) the identification of potential additional benefits of the proposed hub to energy security. (c) Publication of results Not later than 2 years after the date of enactment of this Act, the Secretary and the Secretary of Commerce shall— (1) submit to the Committee on Energy and Commerce of the House of Representatives and the Committees on Energy and Natural Resources and Commerce, Science, and Transportation of the Senate a report describing the results of the study under subsection (a); and (2) publish those results on the Internet websites of the Departments of Energy and Commerce, respectively.

Summary: Appalachian Ethane Storage Hub Study Act This bill directs the Department of Energy and the Department of Commerce to study the feasibility of establishing an ethane storage and distribution hub in the Marcellus, Utica, and Rogersville shale plays located in the Appalachian region of the United States. The study must include potential locations for the hub, the economic feasibility and benefits of the project, infrastructure needs, and potential benefits of the hub to energy security.
Changing the Culture of the FDA Act

To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration. 1. Short title This Act may be cited as the Changing the Culture of the FDA Act 2. Mission Statement of the Food and Drug Administration The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, is directed to amend the mission statement of the Food and Drug Administration to include the following statement: The FDA is also responsible for protecting the public health by strongly considering the danger of addiction and overdose death associated with prescription opioid medications when approving these medications and when regulating the manufacturing, marketing, and distribution of opioid medications.

Summary: Changing the Culture of the FDA Act This bill requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)
FDA Accountability for Public Safety Act

To establish procedures regarding the approval of opioid drugs by the Food and Drug Administration. 1. Short title This Act may be cited as the FDA Accountability for Public Safety Act 2. Approval against the recommendation of the FDA advisory committee on opioid drugs (a) In General Any approval of an application or supplement to an application under section 505(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(b) Public Law 114–198 Commissioner (b) Reports to Congress If the Commissioner approves a drug as described in subsection (a), the Commissioner shall— (1) submit a report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, and to any member of Congress that requests the report, that includes— (A) medical and scientific evidence regarding patient safety that clearly supports the Commissioner's decision to approve the opioid drug against the recommendation of the advisory committee; and (B) a disclosure of any potential conflicts of interest that may exist regarding any official of the Food and Drug Administration who was involved in the decision to approve the drug prior to the Commissioner's final decision under subsection (a); and (2) at the request of the Committee on Health, Education, Labor, and Pensions of the Senate or the Committee on Energy and Commerce of the House of Representatives, testify before that committee regarding the Commissioner's decision to approve the opioid drug against the recommendation of the advisory committee. (c) Prohibition on marketing A drug approved as described in subsection (a) shall not be introduced or delivered for introduction into interstate commerce until the report described in subsection (b)(1) has been submitted to Congress. (d) Scope of advisory committee review Section 106(a)(1)(A) of the Comprehensive Drug and Recovery Act of 2016 ( Public Law 114–198 (1) by inserting , or supplement to an application, application (2) by striking of a new for

Summary: FDA Accountability for Public Safety Act This bill amends the Comprehensive Addiction and Recovery Act of 2016 to expand the scope of the Food and Drug Administration (FDA) advisory committee to make recommendations regarding supplemental applications for opioids. Currently, the committee only makes recommendations on new drug applications. Only the Commissioner of Food and Drugs may approve a new drug application or supplement to an application for an opioid against the recommendation of the committee. If the Commissioner approves a drug against the recommendation of the committee, the Commissioner must: (1) submit a report to Congress that includes the evidence regarding patient safety that supports the Commissioner's decision and a disclosure of any potential conflicts of interest of FDA officials involved in the decision; and (2) testify before Congress regarding the decision, upon request. Such a drug cannot be sold until the Commissioner has submitted the report.
Protecting Americans from Dangerous Opioids Act

To require the Food and Drug Administration to revoke the approval of one opioid pain medication for each new opioid pain medication approved. 1. Short title This Act may be cited as the Protecting Americans from Dangerous Opioids Act 2. Findings Congress finds as follows: (1) Opioids killed more than 33,000 people in the United States in 2015, more than any year on record. Nearly half of all opioid overdose deaths involve a prescription opioid. (2) According to the Centers for Disease Control, 3 out of 4 new heroin users abused prescription opioids before moving to heroin. (3) The United States makes up only 4.6 percent of the world's population, but consumes 80 percent of its opioid pain medications. (4) In 2012, health care providers wrote 259,000,000 prescriptions for painkillers, enough for every individual in the United States to have a bottle of pills. (5) The amount of prescription opioids sold in the United States has nearly quadrupled since 1999 without a reported increase in pain. At the same time overdose deaths involving opioids have also quadrupled since 1999. 3. Requirement to revoke approval (a) In general Notwithstanding any other provision of law, if the Secretary of Health and Human Services (referred to in this section as the Secretary 21 U.S.C. 355 (b) Considerations In determining the drug for which the Secretary will revoke approval pursuant to subsection (a), the Secretary shall— (1) prioritize revocation of non-abuse deterrent formulations of opioid drugs; and (2) consider the public health impact of the opioid drug being on the market.

Summary: Protecting Americans from Dangerous Opioids Act This bill requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.